Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLO1 | Q04760 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 12/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 12/20 | 0.47 |
| ▸ | MAPT | P10636 | 7/20 | 0.47 |
| ▸ | RAB9A | P51151 | 6/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.47 |
| ▸ | HPGD | P15428 | 4/20 | 0.47 |
| ▸ | LMNA | P02545 | 4/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.47 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | CNR2 | P34972 | 1/20 | 0.46 |
| ▸ | GRIN2C | Q14957 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | MITF | O75030 | 1/20 | 0.46 |
| ▸ | KLF5 | Q13887 | 1/20 | 0.46 |
| ▸ | NOD1 | Q9Y239 | 2/20 | 0.45 |
| ▸ | NPC1 | O15118 | 5/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21260701 | 0.85 | MEN1 (0.67) | GLO1MEN1KMT2AMAPTRAB9A | |
| SCHEMBL21260711 | 0.76 | GLO1 (0.45) | GLO1MEN1KMT2AMAPTRAB9A | |
| SCHEMBL22696625 | 0.71 | MEN1 (0.64) | MEN1KMT2AMAPTRAB9ASMN1; SMN2 | |
| SCHEMBL21261019 | 0.71 | RAB7A (0.58) | GLO1MEN1KMT2AMAPTRAB9A | |
| SCHEMBL20711039 | 0.70 | ANO1 (0.64) | MEN1KMT2AMAPTSMN1; SMN2POLB | |
| SCHEMBL22680793 | 0.67 | MEN1 (0.47) | MEN1KMT2AMAPTRAB9ASMN1; SMN2 | |
| SCHEMBL7900681 | 0.66 | MEN1 (0.80) | GLO1MEN1KMT2AMAPTRAB9A | |
| SCHEMBL20541948 | 0.65 | KDM4E (0.75) | MEN1KMT2AMAPTRAB9ASMN1; SMN2 | |
| SCHEMBL21247366 | 0.65 | RAB9A (1.00) | MEN1KMT2AMAPTRAB9ASMN1; SMN2 | |
| SCHEMBL23413350 | 0.65 | GLO1 (1.00) | GLO1MEN1KMT2AMAPTRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200369682-A1 | FUSED THIOPHENE DERIVATIVES AND THEIR USES | ENYO PHARMA (FR) | 2020-11-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200369682-A1 | FUSED THIOPHENE DERIVATIVES AND THEIR USES | FTH1, SLC40A1, FECH | GLO1 616/4885MEN1 3538/4885KMT2A 3454/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.